On May 12, the International Masters Frontier Forum at Sun Yat-sen University was held at the Seventh Affiliated Hospital, Sun Yat-sen University. During this forum, the unveiling ceremony of Edmond H. Fischer Translational Medical Research Laboratory, be it addressed “Nobel Prize Winner Laboratory” in China, is witnessed as well. The lab is titled with an honorary professor to Edmond Fischer, of which lab his student Professor Zhao Zhizhuang is one of the core members.

Professor Edmond Fischer, who won the Nobel Prize in Physiology or Medicine in 1992, is dedicated to the study of protein phosphorylation, particularly the process of cellular regulation by tyrosine phosphorylation. He is the discoverer of tyrosine kinase and the founder of targeted drug therapy.

Professor Zhao Zhizhuang is an international authority in the field of transformational medicine and stem cells. He is also a member of the "Thousand People Program" of the Organization Department of the Central Committee of the CPC, who has joined the Seventh Affiliated Hospital, Sun Yat-sen University.

Based on the discovery of protein phosphorylation by Professor Edmond Fischer, the laboratory will put a high emphasis on developing personalized precision medicine and targeted therapy. To be specific, the lab will focus on studying the mechanisms of cell regeneration, proliferation and differentiation that are associated with diseases, thereby resolving difficulties in treatment for blood, gastrointestinal, breast and nervous system diseases.

The hospital and American Chinese Medical Association had an in-depth discussion and reached an agreement on collaboratively establishing a platform for training high-level medical personnel with an international perspective. This training platform will base at Brigham and Women's Hospital, initiating with specialist cooperation to establish close cooperative relations in clinical practice, scientific research and education. At the same time, the Seventh Affiliated Hospital will play a key role in deepening medical exchanges between China and America.

The American Chinese Medical Association (ACMA), formerly the North American Branch of the Chinese Medical Association, was founded in 1998 by Chinese-American doctors and biomedical scientists. ACMA is one of the world's most famous academic organizations. Its members served in major hospitals and medical research institutes in various states of the United States.

Brigham and Women's Hospital is a teaching Affiliated Hospital of Harvard Medical School with 150 outpatient clinics and 1,200 doctors. It provides treatment for the most complex and critical illnesses in the United States and the world. It is internationally leading in clinical specialties such as cancer, cardiovascular, cardiac surgery, gynecology, neurology, neurosurgery, orthopedics and rheumatology. Therefore, doctors and medical staff from China will have the opportunity to contact the most advanced and cutting-edge international treatment and nursing concepts, management concepts, humanistic concepts, to achieve a comprehensive upgrading of professional technology, management level, scientific research capacity.